Provide personalized onboarding and ongoing adherence support to patients and caregivers throughout their treatment journey.
Coordinate insurance coverage verification, reimbursement support, and financial assistance enrollment for eligible patients.
Serve as the primary point of contact for healthcare providers, resolving access barriers and ensuring seamless coordination with internal teams.
The partner company provides comprehensive non-clinical patient support for individuals managing rare and ultra-rare diseases. They foster a collaborative, patient-focused culture with a remote work environment and a commitment to improving healthcare access.
Complete biopsychosocial assessments to identify clinical, behavioral, and social needs.
Proactively identify and resolve care gaps in patient records, ensuring timely clinician review.
Coordinate referrals, follow-up appointments, and community-based care support services.
Knownwell provides weight-inclusive healthcare for all, offering weight management, primary care, nutrition counseling, and health coaching. They are backed by $50M in funding, scaling fast to expand access to evidence-based obesity care nationwide.
Provide participant-centered vocational assessments and collaborate with Rehabilitation Service Specialists to achieve program outcomes.
Complete comprehensive, accurate reports for Employability and Earnings Capacity Assessments and Transferable Skills Analyses.
Manage monthly billable hours and ensure timely, evidence-based recommendations for rehabilitation plan goals.
WCG partners with governments and agencies across Canada to create sustainable employment opportunities. They are committed to diversity and equity, building an inclusive workplace that develops talent.
Manage end-to-end patient cases for TIL therapy from referral through post-infusion, serving as a primary contact and trusted advisor.
Collaborate with treatment centers, interdisciplinary care teams, and internal partners to coordinate tumor procurement, manufacturing, and time-sensitive milestones.
Identify and resolve barriers to therapy access, track critical milestones, and contribute to continuous improvement and site onboarding best practices.
Iovance Biotherapeutics is a global leader in developing tumor infiltrating lymphocyte (TIL) therapy for cancer, pioneering a transformational approach that harnesses the immune system to attack tumors. The company is committed to continuous innovation in cell therapy, including gene-edited options, and fosters a diverse, inclusive culture.